Losartan rewires the tumor-immune microenvironment and suppresses IGF-1 to overcome resistance to chemo-immunotherapy in ovarian cancer. - Sun Y; Yin Z; Li S; Wu L; Zhang Y; Zhao Y; Gomes Dos Santos IL; Subudhi S; Lei P; Muzikansky A; Yuan Z; Rueda BR; et al. (British journal of cancer, 2024)